"The EPO Opposition Division has upheld a CRISPR/Cas9 patent belonging to the University of California (Berkeley), University of Vienna, and Emmanuelle Charpentier, following a 15-hour hearing. However, it is just one in a multiple-patent family subject to recent EPO proceed...
Continue reading
"Mixed German IP firm Maiwald has strengthened its team with SPC expert Ulrike Herr. She joined in February from Isenbruck Bösl Hörschler, whose Munich office recently disbanded due to a string of departures. Ulrike Herr...
Continue reading
Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of AficamtenRoyalty Pharma Purchases Royalties on Future Sales of Aficamten
Continue reading
All press coverage
The patent attorneys’ firm of Maiwald has put part of its Munich office space at the disposal of the organisation “Münchner Freiwillige – Wir helfen e.V.” to use as a contact point for refugees fleeing Ukraine. From rooms in Elisenhof, located very close to...
Continue reading
Maiwald, together with other leading patent law firms, considers video conferencing without the consent of the parties to be inadmissible and has filed an amicus curiae brief in connection with the proceedings G 1/21 before the Enlarged Board of Appeal of the Europea...
Continue reading
Maiwald is setting up a patent litigation team with partner Dr Simon Lud and two associates. Maiwald is mandated by Unified Patents, LLC, located in the USA.
Continue reading
All press releases